These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health. Ryan M; Ryan SJ Am J Manag Care; 2018 Sep; 24(17 Suppl):S371-S379. PubMed ID: 30312032 [TBL] [Abstract][Full Text] [Related]
3. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Bunschoten C; Jacobs BC; Van den Bergh PYK; Cornblath DR; van Doorn PA Lancet Neurol; 2019 Aug; 18(8):784-794. PubMed ID: 31076244 [TBL] [Abstract][Full Text] [Related]
6. Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy. Saperstein DS; Barohn RJ Curr Neurol Neurosci Rep; 2003 Jan; 3(1):57-63. PubMed ID: 12507413 [TBL] [Abstract][Full Text] [Related]
7. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression. Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593 [TBL] [Abstract][Full Text] [Related]
8. Are the treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) effective and safe? - A Cochrane Overview summary with commentary. Oaklander AL; Gimigliano F NeuroRehabilitation; 2019; 44(4):609-612. PubMed ID: 31256085 [TBL] [Abstract][Full Text] [Related]